Business Context and Reporting Period
Company: Ares Capital Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: June 7, 2012
Event: Entry into a Material Definitive Agreement regarding the amendment of the CP Funding Facility.
Key Financial Metrics and Facility Details
This filing details amendments to the revolving funding facility (CP Funding Facility) rather than reporting period-end financial results. Key facility metrics include:
- Facility Size Increase: Increased from $500 million to $580 million via the addition of two new lenders.
- Expansion Option: Added a provision allowing commitments to be increased up to $865 million.
- Interest Rate: Remained unchanged at LIBOR plus 2.50% (no floor) or Base Rate plus 1.50%.
- Covenants: Borrowings remain subject to Investment Company Act of 1940 leverage restrictions.
Note: The filing text does not provide clear values for revenue, profit, cash flow, margins, or total debt levels for the reporting period.
Material Changes Versus Prior Period
The primary material change is the restructuring of the CP Funding Facility terms:
- Reinvestment Period: Extended from January 18, 2015, to April 18, 2015.
- Maturity Date: Extended from January 18, 2017, to April 18, 2017.
- Lender Base: Expanded to include two new lenders.
Guidance, Outlook, and Risks
Management Commentary: The company issued a press release on June 8, 2012, announcing the amendment. The filing incorporates this press release by reference under Regulation FD.
Risks and Contingencies: The filing notes that borrowings are subject to various covenants and leverage restrictions under the Investment Company Act of 1940. No specific new risks or unusual items were disclosed beyond the facility amendment.
Important Facts for Investor Verification
- Verify the impact of the $80 million facility increase on the company's liquidity and leverage ratios.
- Confirm the identity and creditworthiness of the two new lenders added to the facility.
- Review the full text of the CP Amendment (Exhibits 10.1, 10.2, and 10.3) for detailed covenant language.
- Check the June 8, 2012 press release (Exhibit 99.1) for additional management commentary on the strategic rationale.